These results suggest that abnormally elevated FGF21 levels in healthy aging are not associated with repressed FGF21‐responsiveness machinery of FGF21 responsiveness in adipose tissue, a finding that contrasts with what is observed in obesity and diabetes (Gallego‐Escuredo et al., 2015). This evidence concerns the gene FGF21 and Obesity.